Published in Infect Immun on August 01, 1998
Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories. J Bacteriol (2010) 2.36
Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J Bacteriol (1999) 1.39
Population biology of the human restricted pathogen, Streptococcus pyogenes. Infect Genet Evol (2009) 1.27
Molecular analysis of the Enterococcus faecalis serotype 2 polysaccharide determinant. J Bacteriol (2003) 1.14
Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64. Infect Immun (2000) 1.13
Role of group A streptococcal virulence factors in adherence to keratinocytes. Infect Immun (2000) 1.03
Persistence of Streptococcus pyogenes in stationary-phase cultures. J Bacteriol (2005) 1.01
Role of CsrR, hyaluronic acid, and SpeB in the internalization of Streptococcus pyogenes M type 3 strain by epithelial cells. Infect Immun (2002) 0.87
Generation of metabolically diverse strains of Streptococcus pyogenes during survival in stationary phase. J Bacteriol (2009) 0.84
The sagA/pel locus does not regulate the expression of the M protein of the M1T1 lineage of group A Streptococcus. Virulence (2013) 0.83
Long-term survival of Streptococcus pyogenes in rich media is pH-dependent. Microbiology (2012) 0.78
The prince and the pauper: which one is real? The problem of secondary mutation during mutagenesis in Streptococcus pyogenes. Virulence (2013) 0.75
New method for quantitative determination of uronic acids. Anal Biochem (1973) 27.02
Simple and rapid method for isolating large plasmid DNA from lactic streptococci. Appl Environ Microbiol (1983) 14.59
Census and consensus in bacterial ecosystems: the LuxR-LuxI family of quorum-sensing transcriptional regulators. Annu Rev Microbiol (1996) 10.26
Complete nucleotide sequence of macrolide-lincosamide-streptogramin B-resistance transposon Tn917 in Streptococcus faecalis. J Bacteriol (1985) 7.00
Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun (1980) 5.90
Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems. J Bacteriol (1991) 4.99
Studies of L forms and protoplasts of group A streptococci. I. Isolation, growth, and bacteriologic characteristics. J Exp Med (1959) 4.35
Cell-cell communication in gram-positive bacteria. Annu Rev Microbiol (1997) 3.73
Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis (1995) 3.49
A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog (1993) 2.99
Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest (1997) 2.94
Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci U S A (1993) 2.92
Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide. J Bacteriol (1992) 2.66
An exported peptide functions intracellularly to contribute to cell density signaling in B. subtilis. Cell (1997) 2.48
Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun (1998) 2.44
Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci U S A (1994) 2.39
The group A streptococcal virR49 gene controls expression of four structural vir regulon genes. Infect Immun (1995) 2.33
Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem (1995) 2.31
Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes. J Biol Chem (1990) 2.31
Enterococcus faecalis pheromone binding protein, PrgZ, recruits a chromosomal oligopeptide permease system to import sex pheromone cCF10 for induction of conjugation. Proc Natl Acad Sci U S A (1996) 2.27
Role of mga in growth phase regulation of virulence genes of the group A streptococcus. J Bacteriol (1997) 2.20
Coregulation of type 12 M protein and streptococcal C5a peptidase genes in group A streptococci: evidence for a virulence regulon controlled by the virR locus. J Bacteriol (1990) 2.16
Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Infect Immun (1997) 2.13
The nature of the opaque colony variation in group A streptococci. J Hyg (Lond) (1966) 2.04
Pheromone-inducible conjugation in Enterococcus faecalis: interbacterial and host-parasite chemical communication. J Bacteriol (1995) 2.03
DNA sequence of the serum opacity factor of group A streptococci: identification of a fibronectin-binding repeat domain. Infect Immun (1995) 1.91
Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect Agents Dis (1994) 1.90
Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun (1996) 1.79
Regulation of virulence by environmental signals in group A streptococci: influence of osmolarity, temperature, gas exchange, and iron limitation on emm transcription. Infect Immun (1995) 1.78
Streptococcal cysteine proteinase releases kinins: a virulence mechanism. J Exp Med (1996) 1.77
M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes. Mol Microbiol (1996) 1.71
Expression of M type 12 protein by a group A streptococcus exhibits phaselike variation: evidence for coregulation of colony opacity determinants and M protein. Infect Immun (1987) 1.66
What is the size of the group A streptococcal vir regulon? The Mga regulator affects expression of secreted and surface virulence factors. Med Microbiol Immunol (1996) 1.61
Surface protein-CAT reporter fusions demonstrate differential gene expression in the vir regulon of Streptococcus pyogenes. Mol Microbiol (1992) 1.59
Bacterial persistence and expression of disease. Clin Microbiol Rev (1997) 1.48
Characterization of a novel fibronectin-binding surface protein in group A streptococci. Mol Microbiol (1995) 1.47
Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. J Antimicrob Chemother (1997) 1.44
Invasion of cultured human cells by Streptococcus pyogenes. Res Microbiol (1995) 1.34
Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface. J Biol Chem (1994) 1.28
Adaptation of an osmotically fragile L-form of Streptococcus pyogenes to physiological osmotic conditions and its ability to destroy human heart cells in tissue culture. Infect Immun (1976) 1.24
Three different types of organization of the vir regulon in group A streptococci. Mol Gen Genet (1993) 1.23
Protective immunity to the group A Streptococcus may be only strain specific. Med Microbiol Immunol (1994) 1.06
An intracellular sanctuary for Streptococcus pyogenes in human tonsillar epithelium--studies of asymptomatic carriers and in vitro cultured biopsies. Acta Otolaryngol (1997) 1.04
Invasive group A streptococcal disease. Infect Agents Dis (1996) 1.04
Expression of both M protein and hyaluronic acid capsule by group A streptococcal strains results in a high virulence for chicken embryos. Med Microbiol Immunol (1996) 1.04
High-frequency intracellular infection and erythrogenic toxin A expression undergo phase variation in M1 group A streptococci. Mol Microbiol (1998) 1.03
Immunoglobulins to group A streptococcal surface molecules decrease adherence to and invasion of human pharyngeal cells. Infect Immun (1998) 0.97
Retracted High-frequency invasion of epithelial cells by Streptococcus pyogenes can be activated by fibrinogen and peptides containing the sequence RGD. Infect Immun (1997) 0.96
Measuring resistance to phagocytosis of group A and G streptococci: comparison of direct bactericidal assay and flow cytometry. Med Microbiol Immunol (1995) 0.88
Induction of L-variants in human diploid cells infected by group A streptococci. Infect Immun (1972) 0.86
The Streptococcus and the host. Present and future challenges. Adv Exp Med Biol (1997) 0.78
Incidence of cellular and humoral factors on group A streptococcal L forms. I. Microscopic study of the association of L forms with human polymorphonuclear leucocytes and mouse peritoneal macrophages. Ann Microbiol (Paris) (1973) 0.78
Rapid typing of group A streptococci by the use of DNA amplification and non-radioactive allele-specific oligonucleotide probes. FEMS Microbiol Lett (1994) 5.13
Novel series of plasmid vectors for gene inactivation and expression analysis in group A streptococci (GAS). Gene (1996) 3.34
Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest (1997) 2.94
Characterization of nra, a global negative regulator gene in group A streptococci. Mol Microbiol (1999) 2.56
Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin. Infect Immun (1999) 2.31
Enterococcus faecalis pheromone binding protein, PrgZ, recruits a chromosomal oligopeptide permease system to import sex pheromone cCF10 for induction of conjugation. Proc Natl Acad Sci U S A (1996) 2.27
Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule. Mol Microbiol (2001) 2.24
Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect Immun (1998) 2.00
Nucleotide substitutions and small-scale insertion produce size and antigenic variation in group A streptococcal M1 protein. Mol Microbiol (1993) 1.66
Molecular characterization of group A streptococcal (GAS) oligopeptide permease (opp) and its effect on cysteine protease production. Mol Microbiol (1996) 1.64
What is the size of the group A streptococcal vir regulon? The Mga regulator affects expression of secreted and surface virulence factors. Med Microbiol Immunol (1996) 1.61
Horizontal gene transfer and host specificity of beta-haemolytic streptococci: the role of a putative composite transposon containing scpB and lmb. Mol Microbiol (2001) 1.48
M protein gene typing of Streptococcus pyogenes by nonradioactively labeled oligonucleotide probes. J Clin Microbiol (1992) 1.41
Group A streptococcal rofA gene is involved in the control of several virulence genes and eukaryotic cell attachment and internalization. Infect Immun (2001) 1.40
Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J Bacteriol (1999) 1.39
The SpeB virulence factor of Streptococcus pyogenes, a multifunctional secreted and cell surface molecule with strepadhesin, laminin-binding and cysteine protease activity. Mol Microbiol (2001) 1.37
A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol (1998) 1.36
M or M-like protein gene polymorphisms in human group G streptococci. J Clin Microbiol (1995) 1.31
The role played by the group A streptococcal negative regulator Nra on bacterial interactions with epithelial cells. Mol Microbiol (2001) 1.31
Similarity between the group B and A streptococcal C5a peptidase genes. Infect Immun (1992) 1.27
Phylogenetic analysis of ten black yeast species using nuclear small subunit rRNA gene sequences. Antonie Van Leeuwenhoek (1995) 1.23
Analysis of genes encoding two unique type IIa immunoglobulin G-binding proteins expressed by a single group A streptococcal isolate. Infect Immun (1994) 1.20
Type M12 protein from Streptococcus pyogenes is a receptor for IgG3. J Immunol (1993) 1.11
Genetic inactivation of the extracellular cysteine protease enhances in vitro internalization of group A streptococci by human epithelial and endothelial cells. Microb Pathog (1998) 1.04
Role of group A streptococcal virulence factors in adherence to keratinocytes. Infect Immun (2000) 1.03
Role of emm and mrp genes in the virulence of group A streptococcal isolate 64/14 in a mouse model of skin infection. J Infect Dis (1998) 1.01
Identical genes confer high-level resistance to gentamicin upon Enterococcus faecalis, Enterococcus faecium, and Streptococcus agalactiae. Antimicrob Agents Chemother (1992) 1.01
A co-stimulatory signal through ICAM-beta2 integrin-binding potentiates neutrophil phagocytosis. Nat Med (1999) 0.98
Cysteine protease SpeB expression in group A streptococci is influenced by the nutritional environment but SpeB does not contribute to obtaining essential nutrients. Med Microbiol Immunol (1999) 0.98
[Listeria endophthalmitis]. Ophthalmologe (2005) 0.97
New name for the positive regulator of the M protein of group A streptococcus. Mol Microbiol (1995) 0.95
Identification of key gene products required for acquisition of plasmin-like enzymatic activity by group A streptococci. J Infect Dis (1997) 0.95
Similarities between complement-mediated and streptolysin S-mediated hemolysis. J Biol Chem (2001) 0.91
Inactivation of the cysteine protease SpeB affects hyaluronic acid capsule expression in group A streptococci. Microb Pathog (2000) 0.89
Measuring resistance to phagocytosis of group A and G streptococci: comparison of direct bactericidal assay and flow cytometry. Med Microbiol Immunol (1995) 0.88
Recombinant Staphylococcus aureus exfoliative toxins are not bacterial superantigens. Infect Immun (2000) 0.86
Activation of granulocytes by phorbol-12-myristate-14-acetate (PMA) enhances phagocytosis of Streptococcus pyogenes. Adv Exp Med Biol (1997) 0.84
[Management of an Outbreak with Cases of Nosocomial Pneumonia Caused by a Novel Multi-Drug-Resistant Acinetobacter baumannii Clone]. Pneumologie (2010) 0.84
Inactivation of single genes within the virulence regulon of an M2 group A streptococcal isolate result in differences in virulence for chicken embryos and for mice. Microb Pathog (1997) 0.84
Virulence of group A streptococci in fertile hens eggs is mainly effected by M protein and streptolysin O. Int J Med Microbiol (2001) 0.83
Molecular cloning and nucleotide sequence of the group B streptococcal hemolysin. Zentralbl Bakteriol (1991) 0.83
Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea. Infection (2013) 0.82
Toxin levels in serum correlate with the development of staphylococcal scalded skin syndrome in a murine model. Infect Immun (2001) 0.81
Virulence of Streptococcus pyogenes for chicken embryos after isogenic inactivation of different streptococcal pathogenicity factors. Adv Exp Med Biol (1997) 0.81
An ectoprotein kinase of group C streptococci binds hyaluronan and regulates capsule formation. J Biol Chem (1998) 0.81
Health risks from volatile halogenated hydrocarbons? Sci Total Environ (1981) 0.80
Transfusion reaction due to Klebsiella pneumoniae-contaminated red blood cells: a case report. Transfus Med (2013) 0.80
Different alleles of the fcrA/mrp gene of Streptococcus pyogenes encode M-related proteins exhibiting an identical immunoglobulin-binding pattern. Med Microbiol Immunol (1996) 0.80
Difficulties in species identification within the genus Haemophilus - A pilot study addressing a significant problem for routine diagnostics. Eur J Microbiol Immunol (Bp) (2014) 0.80
Low-grade infection after a total knee arthroplasty caused by Actinomyces naeslundii. J Med Microbiol (2012) 0.79
[Periprosthetic infections following total hip replacement with ESBL-forming bacteria: importance for clinical practice]. Orthopade (2011) 0.79
Use of human preconditioned phagocytes for extracorporeal immune support: introduction of a concept. Ther Apher (2001) 0.78
Characterization of a gene coding for a type IIo bacterial IgG-binding protein. Mol Immunol (1995) 0.78
Subcutaneous fistulae in a patient with femoral hypoplasia due to Actinomyces europaeus and Actinomyces turicensis. Infection (2008) 0.77
The current role of pulsed-field gel electrophoresis in methicillin-resistant Staphylococcus aureus (MRSA) typing and the retrospective identification of outbreaks. Eur J Microbiol Immunol (Bp) (2012) 0.77
[Prophylaxis against infections after needle stick injuries]. Unfallchirurg (2012) 0.76
Summary of the round table discussion on genome structure and regulation of gene expression in streptococci and enterococci. Adv Exp Med Biol (1997) 0.76
Evaluation of antimicrobial effects of novel implant materials by testing the prevention of biofilm formation using a simple small scale medium-throughput growth inhibition assay. Biofouling (2012) 0.76
Bartonella quintana endocarditis of the tricuspid and mitral valves. Thorac Cardiovasc Surg (2011) 0.75
Dose related effects of dexamethasone treatment on the ultrastructure of articular cartilage in rats. Agents Actions (1986) 0.75
Identification of M types of group A streptococci. J Clin Microbiol (1993) 0.75
[Toxic-shock-like-syndrome caused by beta-hemolysing group G streptococci in a multimorbid patient with erysipelas]. Dtsch Med Wochenschr (2006) 0.75
[Infections by Streptococcus pyogenes: new aspects of diagnosis, epidemiology, clinical practice, and therapy]. Immun Infekt (1992) 0.75
[Multiple peritonsillar abscesses caused by Arcanobacterium haemolyticum in a young female]. Dtsch Med Wochenschr (2009) 0.75
Human isolates of large colony-forming beta hemolytic group G streptococci form a distinct clade upon 16S rRNA gene analysis. Adv Exp Med Biol (1997) 0.75
[Postoperative infection of an epigastric hematoma caused by Aeromonas veronii biovar sobria]. Dtsch Med Wochenschr (2006) 0.75
[Experience with the Platelia Candida ELISA for the diagnostics of invasive candidosis in neutropenic patients]. Mycoses (2004) 0.75
[Recurrent tonsillopharyngitis associated with Burkholderia cenocepacia : two case reports]. HNO (2009) 0.75